Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitors.

This Registry, with a centralized review of outcomes, homogeneous data collection (half of which prospective) and long-term follow-up, provides insights for optimizing ITI, with a rationale for further studies in the currently evolving scenario of inhibitor management in HA patients.